Figure 4From: The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivoIHC staining of transgenic mice bladders for A, the cell proliferation marker Ki67 and B, P21 in L-Arginine treated (left panel) and belinostat-treated bladder cancer mice (right panel). Images are representative of 9 belinostat-treated mice and 10 control treated with vehicle alone (L-Arginine) selected by a pathologist. All images at 20× objective magnification.Back to article page